Women’s Health and Ovarian Cancer Prevention
Kira Wynn is determined to do everything she can to steer clear of ovarian cancer, a disease that claimed her mother’s life.
Ms. Wynn recalls, “My mom thought it was just a pulled muscle,” explaining that her mother’s physician suggested physical therapy. However, by the time the diagnosis came, her mother’s ovarian cancer was already at a severe stage, leading to her passing just ten months later.
Despite undergoing genetic testing, no mutation was identified that would confirm Ms. Wynn’s risk for similar cancer. Seeking more information, the 37-year-old consulted Dr. Rebecca Stone, a gynecological oncologist at Johns Hopkins Medicine, only to encounter unexpected insights.
Dr. Stone clarified that the term “ovarian cancer” can be misleading. In fact, almost all cases—particularly the fatal ones—originate from the fallopian tubes. The small percentage of cancers that begin in the ovaries tend to be treatable.
Removing the fallopian tubes, which transport eggs from the ovaries to the uterus, dramatically decreases the likelihood of developing ovarian cancer by nearly 80 percent. This quick procedure can usually be performed alongside other abdominal surgeries, such as hysterectomies or hernia repairs. Yet, Ms. Wynn mentioned that no doctor had previously discussed this option with her.
Dr. Stone acknowledged that many in the medical field, as well as the public, remain unaware of this approach, despite recent endorsements from groups like the American Cancer Society and the European Society of Gynaecological Oncology, urging practitioners to consider tube removal during surgical procedures.
In response, the American Cancer Society is initiating a national campaign to raise awareness among both women and healthcare providers regarding the preventive benefits of removing fallopian tubes. This initiative is planned for rollout next year, as confirmed by spokeswoman Anne Reynolds-Doerr.
Currently, women face an average risk of 1.1 percent for ovarian cancer, a disease notorious for its high mortality rate. Typical screening methods, such as ultrasounds and blood tests, have repeatedly proven ineffective in catching the disease early. By the time symptoms like bloating or abdominal pain manifest, the cancer is often widespread. Standard treatments, which include surgery and chemotherapy, frequently fail to cure advanced cases.
Research indicates that cancerous cells often begin as minuscule traces that escape the fallopian tubes and infiltrate the abdomen, illustrating why early detection is challenging. Dr. Kara Long from the Memorial Sloan Kettering Cancer Center noted that the discovery highlighting the origin of ovarian cancer marked a pivotal moment in understanding the disease.
However, translating this critical knowledge into practice has been a struggle. Dr. Long expressed concern about bridging the gap between scientific evidence and medical application. The foundation for this understanding can be traced back to a Dutch Ph.D. student, Jurgen Piek, who began investigating early signs of cancer in ovaries removed from women with specific genetic mutations. His observations led him to conclude that most ovarian cancers actually originate in the fallopian tubes.
Over the years, extensive research provided a solid basis for recommending the removal of fallopian tubes as a preventive measure. Questions about safety and implications for fertility have been addressed, leading to general acceptance of the practice.
Despite this, Dr. Joseph Sakran, a surgeon at Johns Hopkins Medicine, cautioned that merely having research available isn’t adequate for changing medical standards. Removing fallopian tubes can influence fertility; hence, healthcare providers must communicate the potential effects and allow women space to make informed decisions, particularly in light of historical patterns of forced sterilizations.
In collaboration with the American Cancer Society, Break Through Cancer is conducting a study where women scheduled for abdominal surgeries can view materials highlighting the importance of fallopian tube removal. Women retain the choice to watch the video and decide about the procedure itself without any pressure.
For instance, 79-year-old Rolester Garner, who recently watched the video prior to her hernia repair, was initially unaware of the fallopian tubes’ role in ovarian cancer. After learning the facts, she opted to proceed with tube removal during her surgery on July 13.
Looking back, Dr. Long and Dr. Stone have reviewed cases of ovarian cancer patients to assess prior opportunities for preventive surgery. Shockingly, they found that over a quarter missed a chance to have their tubes removed, highlighting a significant gap in care.
Kristin Buser, 42, experienced similar circumstances. After feeling unwell while training for a race, she was misdiagnosed with irritable bowel issues. However, a CT scan revealed advanced ovarian cancer, confirmed to have originated in her left fallopian tube.
Reflecting on her previous cesarean and tubal ligation, Ms. Buser remarked, “Removing my tubes then would have been simple.” Despite the difficult journey involving multiple treatments, she remains positive, hoping to share her experience to help others avoid similar fates. “My main focus is to move forward and stay hopeful,” she expressed.
